A Phase I Study of Alpha‐1,3‐Galactosyltransferase‐Expressing Allogeneic Renal Cell Carcinoma Immunotherapy in Patients with Refractory Metastatic Renal Cell Carcinoma

LESSONS LEARNED: HyperAcute Renal immunotherapy was well tolerated and demonstrated antitumor activity in patients requiring salvage‐line treatment for metastatic renal cell carcinoma (mRCC). HyperAcute Renal immunotherapy was safely administered with concomitant salvage‐line treatments for mRCC, an...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Hahn, Andrew W., Drake, Charles, Denmeade, Samuel R., Zakharia, Yousef, Maughan, Benjamin L., Kennedy, Eugene, Link, Charles, Vahanian, Nicholas, Hammers, Hans, Agarwal, Neeraj
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011628/
https://ncbi.nlm.nih.gov/pubmed/32043778
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0599
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados